NeuroScientific Biopharmaceuticals clears key US Crohn’s trial hurdle

The Sydney Morning Herald - Oct 13, 2026

NeuroScientific Biopharmaceuticals has landed key US backing for its Phase 2 stem cell Crohn’s trial, green-lighting a planned year-end start subject to final preparations.

Read full article

More News

Oct 13, 2026

Don’t blame Ukraine: Prices go up and up, thanks to Trump’s wars

The US president’s battles with trading partners and Iran are responsible for the elevated US inflation rate – not Ukraine’s bombing of Russian oil refineries.

Oct 13, 2026

Big Egg cartel: Australian suppliers accused of driving up prices

The competition watchdog has alleged Australia’s largest egg supplier of engaging in cartel conduct with a raft of other producers.

Oct 13, 2026

ASX falls after slow session on Wall Street; Tech stocks, miners lead losses

The Australian sharemarket has opened on a weaker note after a selloff in chipmakers left US stocks wavering ahead of the reporting season.

Oct 13, 2026

Fight erupts between union and ABC’s head of news

The ABC’s news boss is staring down the barrel of a staff revolt after threatening a senior journalist with disciplinary action.

Oct 12, 2026

Ray-Ban billionaire heir details drug issues, says he slept with 2000 women as he escalates feud

Leonardo Maria Del Vecchio has given a wide-ranging interview as he ramped up his criticism of the leadership of his family’s company.

Oct 12, 2026

Bed bugs ground Qantas Rome-to-Perth flight

Flight QF6 was cancelled at the weekend and the Boeing 787 Dreamliner involved was booked for extra cleaning after passengers on an earlier flight complained of being bitten.

Oct 12, 2026

Australian shares advance as banks, miners rally

The sharemarket has started the week higher after banks rallied in anticipation of US earnings season.

Oct 12, 2026

Larvotto strikes high-grade jackpot at NSW antimony-gold mine

Larvotto has hit high-grade gold and made a new discovery at its NSW Hillgrove mine, with multiple high-grade hits from the Blacklode and Midas lodes, in addition to a new lode dubbed “Echidna”.

Oct 12, 2026

The tech world believes in second chances, but does Oliver Curtis deserve a third?

There is plenty of blame to share and no shortage of schadenfreude at data centre player Firmus’ failure to launch. But it’s hardly a “great loss for Australia”.

Oct 12, 2026

Critical Resources puts boots on Suriname gold ground

Critical Resources has boots on the ground in Suriname, advancing due diligence on two gold projects as big players like Gold Fields plough capital into the region.

Oct 12, 2026

National petrol prices surge past $2.40 a litre with little relief in sight

Drivers in Australia have not faced pump prices this high since the opening weeks of the Iran war. Things are unlikely to change until the situation is resolved.

Oct 12, 2026

Horizon Gold eyes bigger WA mine after spectacular hits

Horizon Gold has struck 44m at 5.08g/t gold at its 2.3Moz Gum Creek project, pointing to growth beyond its 728,000-ounce definitive feasibility study reserve in WA, as drilling continues.

NeuroScientific Biopharmaceuticals clears key US Crohn’s trial hurdle

More News

Don’t blame Ukraine: Prices go up and up, thanks to Trump’s wars

Big Egg cartel: Australian suppliers accused of driving up prices

ASX falls after slow session on Wall Street; Tech stocks, miners lead losses

Fight erupts between union and ABC’s head of news

Ray-Ban billionaire heir details drug issues, says he slept with 2000 women as he escalates feud

Bed bugs ground Qantas Rome-to-Perth flight

Australian shares advance as banks, miners rally

Larvotto strikes high-grade jackpot at NSW antimony-gold mine

The tech world believes in second chances, but does Oliver Curtis deserve a third?

Critical Resources puts boots on Suriname gold ground

National petrol prices surge past $2.40 a litre with little relief in sight

Horizon Gold eyes bigger WA mine after spectacular hits

Recommended

Dalaroo unearths fresh gold clues 1.25km from African discovery